Authors' reply to the Letters to the Editor discussing main outcomes of the PRODIGE 23 study

被引:0
作者
Conroy, T. [1 ,2 ]
Gourgou, S. [3 ]
Borg, C. [4 ]
机构
[1] Univ Lorraine, Inst Cancerol Lorraine, Nancy, France
[2] Univ Lorraine, INSERM, INSPIIRE, Nancy, France
[3] Univ Montpellier, Inst Reg Canc Montpellier, Montpellier, France
[4] Univ Hosp Besancon, Besancon, France
关键词
COLORECTAL-CANCER; FOLFIRINOX;
D O I
10.1016/j.annonc.2024.10.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:216 / 218
页数:3
相关论文
共 11 条
[1]   Variables with time-varying effects and the Cox model: Some statistical concepts illustrated with a prognostic factor study in breast cancer [J].
Bellera, Carine A. ;
MacGrogan, Gaetan ;
Debled, Marc ;
de lara, Christine Tunon ;
Brouste, Veronique ;
Mathoulin-Pelissier, Simone .
BMC MEDICAL RESEARCH METHODOLOGY, 2010, 10
[2]   Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial [J].
Conroy, T. ;
Castan, F. ;
Etienne, P. -l. ;
Rio, E. ;
Mesgouez-Nebout, N. ;
Evesque, L. ;
Vendrely, V. ;
Artignan, X. ;
Bouche, O. ;
Gargot, D. ;
Boige, V. ;
Bonichon-Lamichhane, N. ;
Louvet, C. ;
Morand, C. ;
de la Fouchardiere, C. ;
Boileve, A. ;
Delaye, M. ;
Gourgou, S. ;
Pezzella, V. ;
Borg, C. .
ANNALS OF ONCOLOGY, 2024, 35 (10) :873-881
[3]  
Conroy T, 2021, LANCET ONCOL, V22, pE302, DOI 10.1016/S1470-2045(21)00340-5
[4]   Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23) : a multicentre, randomised, open-label, phase 3 trial [J].
Conroy, Thierry ;
Bosset, Jean-Francois ;
Etienne, Pierre-Luc ;
Rio, Emmanuel ;
Francois, Eric ;
Mesgouez-Nebout, Nathalie ;
Vendrely, Veronique ;
Artignan, Xavier ;
Bouche, Olivier ;
Gargot, Dany ;
Boige, Valerie ;
Bonichon-Lamichhane, Nathalie ;
Louvet, Christophe ;
Morand, Clotilde ;
de la Fouchardiere, Christelle ;
Lamfichekh, Najib ;
Juzyna, Beata ;
Jouffroy-Zeller, Claire ;
Rullier, Eric ;
Marchal, Frederic ;
Gourgou, Sophie ;
Castan, Florence ;
Borg, Christophe .
LANCET ONCOLOGY, 2021, 22 (05) :702-715
[5]   Oxaliplatin in Adjuvant Colorectal Cancer: Is There a Role in Older Patients? [J].
Dottorini, Lorenzo ;
Petrelli, Fausto ;
Ghidini, Antonio ;
Rea, Carmen Giusy ;
Borgonovo, Karen ;
Dognini, Giuseppina ;
Parati, Maria Chiara ;
Petro, Daniela ;
Ghilardi, Mara ;
Luciani, Andrea .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (18) :3300-+
[6]  
Fernandes B, 2023, 18 EUR SOC COL SCI C
[7]   International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer [J].
Fokas, Emmanouil ;
Appelt, Ane ;
Glynne-Jones, Robert ;
Beets, Geerard ;
Perez, Rodrigo ;
Garcia-Aguilar, Julio ;
Rullier, Eric ;
Joshua Smith, J. ;
Marijnen, Corrie ;
Peters, Femke P. ;
van der Valk, Maxine ;
Beets-Tan, Regina ;
Myint, Arthur S. ;
Gerard, Jean-Pierre ;
Bach, Simon P. ;
Ghadimi, Michael ;
Hofheinz, Ralf D. ;
Bujko, Krzysztof ;
Gani, Cihan ;
Haustermans, Karin ;
Minsky, Bruce D. ;
Ludmir, Ethan ;
West, Nicholas P. ;
Gambacorta, Maria A. ;
Valentini, Vincenzo ;
Buyse, Marc ;
Renehan, Andrew G. ;
Gilbert, Alexandra ;
Sebag-Montefiore, David ;
Roedel, Claus .
NATURE REVIEWS CLINICAL ONCOLOGY, 2021, 18 (12) :805-816
[8]   Folfirinox in elderly patients with pancreatic or colorectal cancer-tolerance and efficacy [J].
Guion-Dusserre, Jean-Florian ;
Bertaut, Aurelie ;
Ghiringhelli, Francois ;
Vincent, Julie ;
Quipourt, Valerie ;
Marilier, Sophie ;
Tharin, Zoe ;
Bengrine-Lefevre, Leila .
WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (42) :9378-9386
[9]  
Li H, 2024, Ann Oncol, V35, P873
[10]   Advancing rectal cancer therapy: mFOLFIRINOX reduces metastasis and improves survival outcomes. Letter to the Editor regarding ' Total neoadjuvant therapy with mFOLFIRINOX versus preoperativechemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial' by Conroy T et al. [J].
Shubhra, Q. T. H. ;
Cai, Q. .
ANNALS OF ONCOLOGY, 2024, 35 (11) :1062-1063